Alberta Investment Management Corp Biomarin Pharmaceutical Inc Transaction History

Alberta Investment Management Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $699,642 - $866,868	9,400 Added 254.05%	13,100 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $159,165 - $176,772	-1,871 Reduced 33.58%	3,700 $327,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $162,178 - $187,661	1,871 Added 50.57%	5,571 $482,000
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $4.04 Million - $5.4 Million	-46,030 Reduced 92.56%	3,700 $359,000
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $186,139 - $249,849	-2,300 Reduced 4.42%	49,730 $5.15 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $2.46 Million - $2.91 Million	-30,000 Reduced 36.57%	52,030 $4.41 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $2.16 Million - $2.63 Million	30,230 Added 58.36%	82,030 $6.8 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $3.06 Million - $3.82 Million	41,200 Added 388.68%	51,800 $3.99 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $800,406 - $898,774	10,600 New	10,600 $884,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $3.6 Million - $4.84 Million	-56,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $1.44 Million - $1.91 Million	-18,000 Reduced 24.32%	56,000 $4.77 Million
Q3 2018 Nov 16, 2018	SELL	$93.92 - $105.72 $3.01 Million - $3.38 Million	-32,000 Reduced 30.19%	74,000 $7.18 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $8.54 Million - $10.1 Million	106,000	106,000 $9.87 Million

636

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.